![](/img/cover-not-exists.png)
Evaluation of second line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first line cediranib
Richter, Suzanne, Seah, Jo-An, Pond, Gregory R, Gan, Hui K, Mackenzie, Mary J., Hotte, Sebastien J., Mukherjee, Som D., Murray, Nevin, Kollmannsberger, Christian, Heng, Daniel, Haider, Masoom A., HalfVolume:
8
Language:
english
Journal:
Canadian Urological Association Journal
DOI:
10.5489/cuaj.2426
Date:
December, 2014
File:
PDF, 3.21 MB
english, 2014